-
Oil extends gains, stocks mostly down as Trump issues fresh Iran warning
-
Mass Russian barrage kills 12 in Kyiv
-
ThinkMarkets Expands Weekend Trading Offering, Launches Weekend League Competition
-
PineX Capital Launches MetaTrader 5 as Prop Firm Expands Trading Platform Offering
-
Tibet activists accuse China of downplaying floods
-
Women survivors face sanitation woes in Nepal relief camp
-
Afghanistan war victims left 'without justice', UN says
-
Oil extends gains, stocks mixed as Trump issues fresh Iran warning
-
Iran president offers US olive branch before Putin meeting
-
Thai resort readies for US carrier's 5,000 sailors
-
China-Nepal flood toll tops 1,000 as tunnel rescue offers last hope
-
AI startup Manus says resumes independent operations
-
Japan to relax overtime regulation under workaholic PM
-
'Massive' Russian missile, drone attack on Kyiv kills 8
-
Thwarted Niger mutiny exposes junta's Russia dependence
-
Defence tech hub Munich booms as Europe rearms
-
Illegal mining ravages S.Africa's economic hub
-
Nigeria rethinks criminalisation of suicide
-
Nepal's wall of missing offers last hope after Himalayan flood
-
Osaka channels NBA icon Iverson to reach US Open second round
-
US to press G20 on light-touch AI regulation
-
Fast-fashion giant Shein plunges 10% on Hong Kong debut
-
2 die in Grand Canyon flash flood, only 1 person unaccounted for
-
South Korea hire former Spain boss Moreno as interim coach
-
US Army Secretary Driscoll submits resignation: White House
-
China-Taiwan friction clouds Pacific summit
-
Oil extends gains, stocks drop as Trump issues fresh Iran warning
-
Two dead after stabbing in New York's Times Square
-
Tsitsipas says Kyrgios's positive cocaine test 'kind of expected'
-
Anthropic signs $35B computing deal with startup backed by Nvidia
-
In Japan's mountains, a different way to manage bears
-
Drones in Ithaca: Azov's Odyssey turns Ukraine war into modern myth
-
Middle East war a boon for UAE defence giant with global ambitions
-
Boat builders keep Pakistan's fishing heritage afloat
-
Former gang member found guilty of murdering Tupac Shakur
-
Australia axe Labuschagne for Zimbabwe, South Africa ODI series
-
Top-seeded Zverev opens US Open campaign
-
Heavy rain at Grand Canyon after flood kills 2, dozen missing
-
US regulator, 22 states accuse Amazon of 'manipulating' ad auctions: lawsuit
-
Kushner blames soccer power struggle for World Cup plan collapse
-
TRON Founder Justin Sun Shares Outlook on Bitcoin, Stablecoins and Global Finance at Bitcoin Asia 2026
-
Buoyant Alcaraz shakes off nerves to advance at US Open
-
Tributes to 'eternal' Messi on Argentina retirement
-
US draws European pushback with Russia G20 finance invite
-
Arteta hails Arsenal's 'finishers' after Saka kills off Villa
-
Jury begins deliberations in Tupac Shakur murder trial
-
Yamal, Raphinha bag braces as Barcelona rout Rayo
-
US Supreme Court allows Trump ballroom project to proceed
-
Alcaraz makes winning return at US Open, Sabalenka safely through
-
Trump says US reviewing position on Falkland Islands
Most baby formula health claims not backed by science: study
The vast majority of health claims used to advertise baby formula worldwide are not supported by rigorous scientific evidence, a study said Thursday, leading researchers to urge the breast milk substitutes be sold in plain packaging.
The study comes a week after a group of doctors and scientists called for a regulatory crackdown on the $55-billion formula industry for "predatory" marketing which they said exploits the fears of new parents to convince them not to breastfeed.
Breastfeeding is widely recognised to have huge health benefits for babies. The World Health Organization and the US CDC recommend breastfeeding exclusively during the first six months of a newborn's life.
However that recommendation is followed for less than half of infants globally, according to the WHO.
Daniel Munblit, an honorary senior lecturer at Imperial College London and an author of the new study, said researchers were not on a "crusade" against infant formula, which should remain an option for mothers who cannot or choose not to breastfeed.
"But we are very much against inappropriate infant formula marketing, which provides misleading claims not backed up by solid evidence," Munblit told AFP.
Munblit and an international team of researchers looked at the health claims made for 608 products on the websites of infant formula companies in 15 countries, including the United States, India, Britain and Nigeria.
The most common claims were that formula supports brain development, strengthens immune systems and more broadly helps growth.
Half of the products did not link the claimed health benefit to a specific ingredient, according to the study published in the BMJ journal.
Three quarters did not refer to scientific evidence supporting their claims.
Of those that provided a scientific reference, more than half pointed to reviews, opinion pieces or research on animals.
Just 14 percent of the products referred to registered clinical trials on humans. However 90 percent of those trials carried a high risk of bias, including missing data or the finding not supporting the claim, the study said.
And nearly 90 percent of the clinical trials had authors who received funding from or had ties to the formula industry, it added.
- 'Distressing' -
The most commonly cited ingredient was polyunsaturated fatty acids, which is in breast milk and is considered important for brain development.
However there is no evidence of any added benefit when the ingredient is added to baby formula, according to a Cochrane systematic review.
Munblit said the health claims were mostly used to advertise premium formula products, which could be "distressing" for parents who are misled into believing the ingredients are essential but cannot afford them.
When asked what he thinks needs to be done to address the problem, Munblit was concise.
"Plain packaging," he said.
The study comes after a series of papers were published in the Lancet journal last week calling for global policy makers to end exploitative formula marketing.
WHO infant health specialist Nigel Rollins, an author of one of the Lancet papers, said busy parents "lack the time to properly scrutinise claims" about infant formula.
The new study showed that "governments and regulatory authorities must commit the necessary time and attention to review the claims of formula milk products," Rollins said in a linked BMJ editorial.
P.Queiroz--PC